Department of Medicine, MedStar Union Memorial Hospital, Baltimore, United States.
Department of Cardiology, SUNY Upstate Medical University, Syracuse, United States.
Curr Probl Cardiol. 2024 Dec;49(12):102873. doi: 10.1016/j.cpcardiol.2024.102873. Epub 2024 Oct 4.
Atrial fibrillation (AF), is an irregular heart rhythm disorder that increases the risk of stroke, heart failure, and death. Obstructive sleep apnea is typified by intermittent airway blockages which results in low oxygen levels and disrupted sleep. These two conditions often coexist, with each worsening the other. Understanding this connection is critical to improve diagnosis and treatment. The relationship between atrial fibrillation and obstructive sleep apnea appears bidirectional. Obstructive sleep apnea increases the risk of atrial fibrillation through various mechanisms which are arrhythmogenic. Conversely, patients with atrial fibrillation are more likely to have undiagnosed obstructive sleep apnea, complicating their treatment. Screening modalities for obstructive sleep apnea are often inadequate. Polysomnography remains the most reliable tool but is costly and not practical for routine screening of all patients which limits early diagnosis and management. Continuous positive airway pressure (CPAP) therapy is the primary treatment for obstructive sleep apnea and can reduce atrial fibrillation recurrence by decreasing oxygen deprivation and sympathetic activity. However, adherence to continuous positive airway pressure is often low due to patient discomfort. Alternative therapies, such as mandibular advancement devices and hypoglossal nerve stimulation, offer promising options for patients who cannot tolerate continuous positive airway pressure. The interplay between atrial fibrillation and obstructive sleep apnea requires an integrated approach to diagnosis and treatment. Improving screening tools, enhancing treatment adherence, and evaluating alternative therapies are critical steps to reducing the impact of these conditions and improving patient outcomes.
心房颤动(AF)是一种不规则的心律紊乱疾病,会增加中风、心力衰竭和死亡的风险。阻塞性睡眠呼吸暂停的特点是间歇性气道阻塞,导致低氧水平和睡眠中断。这两种情况通常同时存在,相互恶化。了解这种联系对于改善诊断和治疗至关重要。心房颤动和阻塞性睡眠呼吸暂停之间的关系似乎是双向的。阻塞性睡眠呼吸暂停通过各种致心律失常机制增加了心房颤动的风险。相反,患有心房颤动的患者更有可能患有未确诊的阻塞性睡眠呼吸暂停,使他们的治疗变得复杂。阻塞性睡眠呼吸暂停的筛查方法往往不够充分。多导睡眠图仍然是最可靠的工具,但成本高,不适用于所有患者的常规筛查,限制了早期诊断和管理。持续气道正压通气(CPAP)治疗是阻塞性睡眠呼吸暂停的主要治疗方法,通过减少缺氧和交感神经活动可以降低心房颤动的复发率。然而,由于患者不适,持续气道正压通气的依从性往往较低。下颌前伸装置和舌下神经刺激等替代疗法为不能耐受持续气道正压通气的患者提供了有前途的选择。心房颤动和阻塞性睡眠呼吸暂停之间的相互作用需要综合的诊断和治疗方法。改善筛查工具、提高治疗依从性和评估替代疗法是减少这些疾病影响和改善患者预后的关键步骤。